BioPacific Conference 2012 Agenda

Theme: Changing Landscape of Global Biopharmaceutical R&D Innovation and Collaboration

June 2, 2012, Crowne Plaza Hotel, Foster City, California, USA

8:00 – 9:00 am Registration and Vendor Exhibits
9:00 – 9:05 am Welcome Remarks
Wentao Zhang, Ph.D., CABS President-Elect, BioPacific Organizing Committee Chair
9:05 – 9:15 am State of the Society
Janet Xiao, Ph.D., CABS President
  Session I: Biopharmaceutical R&D Innovation: Trends, Successes & Challenges
Session Chairs: Connie Sun Ph.D., & Charlene Liao Ph.D.
9:15 – 9:40 am Peter Hirth, Ph.D., CEO, Plexxikon
“Personalized Medicine – Vemurafenib for the Treatment of V600 B-Raf Positive Metastatic Melanoma”
9:40 – 10.05 am Ann Lee, Ph.D., Senior VP, Genentech, Head of Global Technical Development, Roche
“Process Technology and Manufacturing Innovations in Support of Drug Development”
10:05 – 10.30 am Susan Molineaux, Ph.D., Founder, President and CEO, Calithera
“The Challenges of Building an Innovative Drug Discovery Biotech Company in Today’s Economy”
10:30 – 10:50 am Break, Networking, and Vendor Exhibits
  Session II: Breakthroughs in Biomedical Research and Drug Discovery
Session Chairs: Alan Hao, Ph.D., & Jiangwen Majeti, Ph.D., MBA
10:50 – 11:15 am Rusty Williams, M.D., Ph.D., CEO, FivePrime
“Discovery of New Ligand Trap and Antibody drugs”
11:15 – 11:40 am Philip Beachy, Ph.D., Ernest and Amelia Gallo Professor, Stanford University School of Medicine, Investigator, HHMI
“The Hedgehog Pathway: Biology and Therapeutics”
11:40 – 12:05 pm Sasha Kamb, Ph.D., Senior VP, Discovery Research, Amgen
“A Stronger Spine: Lessons from an Innovative Bone Drug”
12:05 – 12:25 pm Connie Sun, Senior VP, Oncology Services, Pharmaron, Gold Sponsor
Nathan Bach, BD Manager, GenScript, Gold Sponsor
12:25 – 1:25 pm Lunch
  Session III: Industry Collaborations: Rising Importance of Academia and Foundations
Session Chairs: Zhonghua Pei, Ph.D., & Chi-Hui Tang, Ph.D.
1:30 – 1:55 pm Rick Lindberg, Ph.D., Head, Pfizer Centers for Therapeutic Innovation-California
“CTI: A New Model for Accelerating Translation of Basic Science to the Clinic”
1:55 – 2:15 pm Keting Chu, M.D., Ph.D., VP, Leukemia & Lymphoma Society
“Partnering with The Leukemia and Lymphoma Society”
2:15 – 2:35 pm Van Ellis, J.D., Partner, Morrison & Foerster LLP
“The Rise of Industry-Academic Collaborations: Opportunities Amid Increased Funding Pressure”
2:35 – 2:55 pm Honggang Bi, VP, Covance, General Manager, Covance China, Gold Sponsor
Mingzhu Zhang, VP, Medicilon, Gold Sponsor
2:55 – 3:15 pm Break, Networking, and Vendor Exhibits
  Session IV: Landscape & Emerging Models in U.S./China Collaborations
Session Chairs: John Mao, Ph.D., & Josh Xiao, Ph.D.
3:15 – 3:40 pm Kenneth Hillan, M.D., CEO and CMO, Achaogen
“Enter the Dragon”
3:40 – 4:05 pm Guo-Liang Yu, Ph.D., CEO and Chairman, Epitomics
“Better antibodies, better science: the journey of Epitomics Inc.”
4:05 – 4:30 pm Qing Dong, Ph.D., CSO, Shanghai Hengrui Pharmaceutical Co.
“Drug Discovery and Development in China: the Hengrui Experience”
4:30 – 4:55 pm Zhenping Zhu, M.D., Ph.D., Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation, and President and CEO of Kadmon China
“New R&D Paradigm for Innovative Medicine”
4:55 – 5:55 pm Panel Discussion: Emerging U.S./China R&D Collaboration and Business Models
Moderator: Greg Scott, President and Founder, ChinaBio LLC
Panelists: Kenneth Hillan, Qing Dong, Guo-Liang Yu, Zhenping Zhu, and Chen Chen, CEO, Sundia Meditech, Richard Soll, SVP, WuXi AppTec
5:55 – 6:15 pm

Piu (Bill) Chan, President and CEO, Wincon Theracells, Gold Sponsor
Wayne Li, General Manager, Kunming Biomed International, Gold Sponsor

6:15 – 7:15 pm Dinner
6:15 – 6:40 pm Richard Liu, Chief Representative, Xi’an Hi-Tech Park (西安高新技术产业开发区驻美首席代表)
Introduction of Xi’an Hi-Tech Park
  Session V: Entrepreneurship and Opportunities: West Meets East
Session Chair: Wentao Zhang, Ph.D., & Hua Tu, Ph.D.
7:15 – 7:40 pm Kenneth Fong, Ph.D., Chairman, Kenson Ventures, LLC
“What Are Successful Biotech Entrepreneurs Made Of?”
7:40 – 9:30 pm Panel Discussion: Successful Entrepreneurship: Opportunities in the U.S. and China
Moderator: Josh Xiao, Ph.D.
Panelists: Guo-Liang Yu, and
Ben P. Chen, Managing Partner, Ignatius Transaction Partners
Charles Hsu, Ph.D., Senior Advisor, Mustang Ventures
Wayne Li, Ph.D., Manager, Morningside Technologies (晨兴科技风险投资公司)
Cheng Liu, Ph.D., Founder and CEO, Eureka Therapeutics
Kristina Burow, MBA, Managing Director, ARCH Venture Partners
Wang Shen, Ph.D., Founder & CEO, Kanion USA
Alex Wu, Ph.D., Co-Founder and CEO, Crown Biosciences
Qiang Xu, Ph.D., Principal, Decheng Capital (德诚资本)
9:30 pm Adjourned